BASF to sell Illinois site
BASF has agreed to sell its manufacturing site in Kankakee, Illinois and the associated businesses of vegetable-oil-based raw material sterols and natural vitamin E, anionic surfactants and esters to private equity firm One Rock Capital Partners. Terms are not being disclosed. Subject to regulatory approval, this should be completed in 1H 2021.
The site, which is operated by the Nutrition & Health and the Care Chemicals divisions, came with the acquisition of Cognis in 2010 and it now employs about 160. BASF regarded Kanakee as no longer a strategic fit. The company continues to produce anionic surfactants for the home care, personal care and industrial formulation sectors at other sites.
RELATED ARTICLES
The US Environmental Protection Agency (EPA) has taken two separate actions on per- and polyfluorinated substances (PFAS), both being part of its PFAS strategic roadmap, which aims to implement legislation by Q4 to reduce and destroy PFAS contamination in water, air and soil.
The first joint Europe-wide assessment of the drivers and impact of chemical pollution by the European Environment Agency (EEA) and the European Chemicals Agency (ECHA) has concluded that, despite progress in some areas, “more work is still needed to reduce the impact of harmful substances on hum
Lubrizol has opened a new Global Capability Centre (GCC) in Pune, India, as “a strategic hub to accelerate its growth in the region and enable closer collaboration for its customers and employees”.
International Process Plants (IPP), which buys and sells industrial plants and equipment, has acquired Henkel’s detergent plant in Lomazzo, Italy, in partnership with Maynards, a specialist in industrial liquidation auction services.
Chemours has completed its planned procedures with respect to an internal review that it first announced on 29 February. This essentially confirmed the details revealed in an interim report on 7 March.
Symrise and India’s Virchow Group have agreed to make personal care ingredients from the Symrise portfolio through a new joint venture called Vizag Care Ingredients, beginning within 1H. This will be based on Virchow’s synthetic chemistry capabilities for API manufacture.
